FDA Inspection
Marksans Pharma LimitedMarksans Pharma Limited – FDA Inspection, Aug 4, 2023
Record Details
This FDA Inspection record concerns Marksans Pharma Limited, with an inspection on August 4, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · c9be8b10-5680-4647-b08f-a6c1655bc9e9
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1211415
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 310.305(c)Failure to submit ADE report
- 21 CFR 314.80(b)Failure to develop written procedures
- 21 CFR 310.305(c)Failure to submit ADE report
- 21 CFR 314.80(b)Failure to develop written procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Marksans Pharma Limited
6| Date | Classification | Office | Project area |
|---|---|---|---|
| April 17, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 6, 2019 | Not classified | Office of Inspections and Investigations | |
| April 7, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 3, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 3, 2012 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Marksans Pharma Limited
- FDA Inspection 1236614 - 2024-04-17
- FDA Inspection 1086017 - 2019-03-06
- FDA Inspection 1014460 - 2017-04-07
- FDA Inspection 944722 - 2015-09-03
- FDA Inspection 795367 - 2012-08-03
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.